NOTCH1 and prostate carcinoma: Knockdown of Notch1 decreased cell proliferation and increased the sensitivity of prostate cells to benzalotamide, indicating that Notch1 signaling plays an important role in the production of enzalutamide resistance in prostate cancer, and inhibition of Notch1 signaling restored the sensitivity of resistant cells to enzalutamide [108].